Rise in Severe Acute Malnutrition in children a major worry: CMAM Association
By IANS |
Published on
Thu, Jan 14 2021 12:57 IST |
0 Views
Rise in Severe Acute Malnutrition in children a major worry: CMAM Association (IANSlife). Image Source: IANS News
New Delhi, Jan 14 : The results of the Phase 1 of the 5th National Family Health Survey (NFHS-5) released by the Ministry of Health and Family Welfare recently, show that there has been an increase in the percentage of severely wasted children under five years of age, in as many as 16 out of the 22 surveyed states and union territories in NFHS-5 in comparison to NFHS-4.
Breaking news live updates: Fire breaks out at Sulonguri Newtown area of Kolkata
Breaking news live updates: Fire breaks out at Sulonguri Newtown area of Kolkata
Stay here for real-time updates on breaking news from India and across the world that you can t miss:
THE TIMES OF INDIA | Jan 14, 2021, 21:45:03 IST
FacebookTwitterLinkedinEMail
21:45 (IST) Jan 14
West Bengal BJP leaders Dilip Ghosh, Amitava Chakraborty & others will come to Delhi tomorrow to meet with the Central BJP leadership: ANI
21:33 (IST) Jan 14
Devotees performed rituals today evening, on Makaravilakku day, in the Sabarimala Temple: ANI
21:31 (IST) Jan 14
Col Prithipal Singh (Retd), the veteran who recently celebrated his 100th birthday and has the unique distinction of serving in all three services was presented with a Silver Salver on behalf of Chief of Defence Staff, General Bipin Rawat on the occasion of Veterans Day, today: ANI
One Chinese vaccine and 4 efficacy rates confuse experts, raise doubts
Premium
A medical worker shows a syringe with the Sinovac Biotech vaccine against the COVID-19 coronavirus at a healthcare centre.
(AFP)
. Updated: 13 Jan 2021, 09:56 AM IST Bloomberg
Uncertainty swirls over the efficacy of the leading Chinese shot, for which four different protection rate numbers have been released in recent weeks
Overlapping efficacy data is not unprecedented in the Covid-19 vaccine race
Share Via
Read Full Story
Days before a global rollout kicks off with the President of Indonesia receiving the Sinovac Biotech Ltd. vaccine on live television, uncertainty swirls over the efficacy of the leading Chinese shot, for which four different protection rate numbers have been released in recent weeks.
Maharashtra needs a total of 17.5 lakh vaccine doses, but we have been able to acquire 55% of the required number as of now, said state health minister Rajesh Tope. Any apprehension being expressed on account of deficient (Covid vaccine) supply is totally baseless and unfounded, says MoHFW
China vaccine’s low efficacy due to high-risk group: Sinovac CEO Yin Weidong
Premium
(Photo: Reuters)
. Updated: 13 Jan 2021, 04:19 PM IST Bloomberg
Chinese vaccine developer Sinovac Biotech CEO Yin Weidong said the low efficacy rate of 50.38% from its final-stage trial in Brazil is due to trial participants being medical workers facing a high risk of contracting Covid-19
Share Via
Read Full Story
Chinese vaccine developer Sinovac Biotech Ltd. said that the low efficacy rate of 50.38% from its final-stage trial in Brazil is due to trial participants being medical workers facing a high risk of contracting Covid-19.
In contrast, western vaccines like that developed by Pfizer Inc. and BioNTech SE were tested among volunteers including people from the general population, some of whom were less exposed to the virus in their daily lives compared to medical workers.